Microbiome Connect: Gut Therapeutics is back, face to face! This year, you will see numerous sessions dedicated to answering the arising challenges in both R&D and manufacturing.

The new 2022 dedicated manufacturing stream will provide you with the essential knowledge required to upskill your manufacturing capabilities. Attendees will hear from the FDA, Takeda, 4D Pharma, BiomX and more, who will share thoughts on best practices on manufacturing LBP's and provide solutions in overcoming difficulties in upscaling regulatory clearance and batch consistency. So take advantage of joining industry leaders who are here to help develop your product pipeline.

The R&D stream will provide solutions to the hurdles in clinical progression, pipeline expansion and analytical standardization. This is an opportunity for you to; optimize patient outcomes by learning to leverage parallel microbiome modulating with Scaled Microbiomics, BiomX and Servactus and progress in clinical trials by identifying different biomarkers with Rebiotix & Takeda. Finally, get ready to take your product to the market by learning from Seres, Finch Therapeutics, Evelo Biosciences and Vedanta Biosciences on the pipeline development of C.difficle.

Find out more here or use the green "Request Information" button below to contact the event organiser.